Danone Enhances Health Portfolio with Acquisition of Functional Formularies

Headquartered in the United States, Functional Formularies specializes in developing formulas tailored to offer essential nutrients and support for individuals facing challenges in consuming solid foods due to various health conditions.

Crafted from organic, whole-food ingredients, Functional Formularies' products stand out for their commitment to avoiding artificial additives and preservatives commonly found in conventional nutritional supplements.

This strategic acquisition underscores Danone's dedication to meeting the growing demand for nutritional products that prioritize health and wellness. By integrating Functional Formularies into its portfolio, Danone aims to reinforce its presence in the health and nutrition sector while delivering innovative and premium-quality nutritional solutions to consumers.

Aligned with the Renew Danone strategy, this acquisition strengthens Danone's medical nutrition offerings in the US, particularly in the enteral tube feeding segment.

Juergen Esser, Deputy CEO and CFO at Danone, expressed enthusiasm about the acquisition, stating, "As a global leader in medical nutrition, we are thrilled to welcome Functional Formularies to Danone. With the addition of their highly differentiated product portfolio, which complements our existing Real Food Blends branded range, we are poised to better address the nutritional needs of tube-fed families and patients."